Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients.

Additionally, we found a positive trend, albeit not significant, for higher IL-2 production by B cells from responding patients ( Figure 2(c )).

also in 11,005 other papers

Interestingly, responder patients showed a trend for more IL-2 production ( Figure 2(d )), a cytokine that supports T cell responses.

also in 53,322 other papers